Alanine aminotransferase (ALT) biochemical analysis is a fundamental laboratory test used to assess liver function and detect hepatocellular injury with high specificity. This technical guide covers the enzymatic reaction principles, sample requirements, analytical methods, and clinical applications of ALT determination in clinical and research settings. Understanding the biochemistry behind ALT measurement is essential for accurate interpretation of liver health markers.
Technical Overview
Alanine aminotransferase (ALT, EC 2.6.1.2), formerly known as serum glutamate pyruvate transaminase (SGPT), is a pyridoxal phosphate-dependent enzyme that catalyzes the reversible transfer of an amino group from L-alanine to alpha-ketoglutarate, yielding pyruvate and L-glutamate. The enzyme is found predominantly in the cytosol of hepatocytes, with lower concentrations in the kidney, heart, and skeletal muscle. Because of its high intracellular concentration in liver tissue and its relatively liver-specific distribution, ALT is widely regarded as the most sensitive and specific serum biomarker of hepatocellular damage.
When hepatocytes are injured by viral infection, toxins, ischemia, or metabolic stress, ALT is released into the bloodstream, causing serum activity to rise, often before clinical symptoms appear. Biochemical analysis of ALT activity therefore serves as a first-line diagnostic tool in hepatology, toxicology, and general health screening. Modern ALT assays quantify catalytic activity in units per liter (U/L), where one unit is defined as the amount of enzyme catalyzing the conversion of one micromole of substrate per minute under standardized conditions.
Testing Samples
Serum
Serum is the preferred specimen for routine ALT analysis. Venous blood is collected into a plain tube or serum separator tube, allowed to clot for 30 minutes at room temperature, and centrifuged to obtain clear serum. Serum ALT is stable for approximately 24 hours at 2–8°C and for several days at -20°C when properly stored. Fasting collection is recommended to reduce lipemic interference, although ALT activity itself is not significantly affected by recent meals.
Plasma
Plasma collected with lithium heparin or EDTA anticoagulants is acceptable on most automated chemistry analyzers, provided the manufacturer's specifications are followed. Citrate and oxalate anticoagulants should be avoided because they can interfere with the enzymatic reaction or dilute the sample. Results from plasma may differ slightly from serum due to the absence of clotting-related volume displacement.
Sample Handling and Interferences
Several pre-analytical factors can compromise ALT measurement accuracy:
- Hemolysis: erythrocytes contain intracellular ALT, and even mild hemolysis may falsely elevate results, so grossly hemolyzed specimens should be rejected.
- Lipemia: turbidity scatters light at 340 nm and interferes with photometric detection; ultracentrifugation or lipid-clearing agents may be required.
- Icterus: high bilirubin concentrations can absorb near the monitoring wavelength and bias kinetic readings.
- Storage: repeated freeze-thaw cycles should be avoided, as they can degrade enzymatic activity.
Testing Items
The primary measured parameter in ALT biochemical analysis is the catalytic activity concentration in serum or plasma, reported in U/L (equivalent to μkat/L conversions in some regions). Typical reference intervals established by the IFCC method at 37°C are approximately 9–50 U/L for adult men and 7–35 U/L for adult women, although laboratories must validate their own ranges based on instrumentation and population. ALT is routinely interpreted alongside companion analytes in a liver panel, including aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), total bilirubin, and albumin. The AST/ALT ratio (De Ritis ratio) provides additional diagnostic discrimination, with ratios above 2.0 often suggesting alcoholic liver disease and elevated ALT-predominant patterns pointing toward viral or metabolic hepatitis.
Testing Methods
IFCC Recommended UV Kinetic Method
The internationally standardized method, recommended by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), is a coupled-enzyme UV kinetic assay performed at 37°C. In the primary reaction, ALT converts L-alanine and alpha-ketoglutarate into pyruvate and L-glutamate. In the indicator reaction, lactate dehydrogenase (LDH) reduces the pyruvate to lactate while oxidizing NADH to NAD+. The decrease in NADH absorbance, monitored continuously at 340 nm (334 or 365 nm on some instruments), is directly proportional to ALT activity. This two-step coupled scheme ensures linearity, high specificity, and excellent precision on automated chemistry analyzers.
Colorimetric Endpoint Methods
Historically, the Reitman-Frankel method was widely used, in which generated pyruvate reacts with 2,4-dinitrophenylhydrazine to form a colored hydrazone measured spectrophotometrically around 500–520 nm. Although inexpensive, this endpoint approach suffers from lower specificity, interference from keto-acids, and narrower linearity, and it has largely been replaced by the kinetic method in modern laboratories.
Point-of-Care and Dry Chemistry Systems
Portable dry-chemistry analyzers and POCT devices employ reagent-impregnated test strips or cassettes that miniaturize the enzymatic reaction, delivering ALT results within minutes from a fingerstick or venous sample. These platforms are valuable in blood donor screening, field surveys, and resource-limited settings, though their analytical performance should be verified against central laboratory methods.
Applications
ALT biochemical analysis supports a broad spectrum of clinical, pharmaceutical, and research applications:
- Clinical diagnosis: detection and grading of acute viral hepatitis, chronic hepatitis B and C, autoimmune hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease (NAFLD/NASH), and cirrhosis.
- Drug safety monitoring: surveillance of hepatotoxicity during therapy with statins, antituberculosis agents, methotrexate, immunomodulators, and oncology treatments, enabling timely dose adjustment.
- Health screening: routine physical examinations and occupational health programs identify asymptomatic liver dysfunction and guide lifestyle intervention.
- Blood donor screening: ALT testing historically served as a surrogate marker for non-A, non-B hepatitis before specific viral assays became available.
- Preclinical research and toxicology: ALT activity in animal serum is a core endpoint in hepatotoxicity studies, drug candidate evaluation, and liver injury models in rodents and larger species.
- Transplant medicine: serial ALT monitoring assesses graft function and detects rejection or ischemic injury following liver transplantation.
FAQ
What does an elevated ALT level mean? Elevated serum ALT indicates hepatocellular injury, as the enzyme leaks from damaged liver cells into the circulation. Mild increases (up to 5 times the upper limit of normal) are commonly associated with fatty liver disease, alcohol consumption, or medication effects, whereas marked elevations above 10 times the limit strongly suggest acute viral hepatitis, toxic injury, or ischemic hepatitis.
What is considered a normal ALT range? Using the IFCC 37°C kinetic method, typical adult reference intervals are approximately 9–50 U/L for men and 7–35 U/L for women. Values vary by age, sex, body mass index, and analytical platform, so results should always be interpreted against the reference interval of the performing laboratory.
Can ALT be measured in animal samples? Yes. The same coupled UV kinetic principle applies to serum or plasma from rodents, dogs, monkeys, and other species, making ALT a standard biomarker in preclinical toxicology and liver research, though species-specific reference ranges must be used.
How should samples be stored before analysis? Serum or plasma should be separated from cells promptly and analyzed within 24 hours when stored at 2–8°C. For longer storage, samples can be frozen at -20°C or below, avoiding repeated freeze-thaw cycles to preserve enzymatic activity.
What factors other than liver disease can raise ALT? Intense exercise, muscle injury, hypothyroidism, celiac disease, obesity, and recent alcohol intake can modestly increase ALT, which is why results are interpreted together with clinical context and other liver function tests.